FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891382714> ?p ?o ?g. }

• W2891382714 endingPage "42" @default.
• W2891382714 startingPage "35" @default.
• W2891382714 abstract "Objectives The expression of immune checkpoint ligand PD-L1 has been reported in various tumors. The expression of IDO and FOXP3 Tregs are considered to be associated with tumor-induced tolerance and poor outcome. Their prognostic role in surgically treated thymoma and thymic carcinoma, however, has not been investigated. Materials and Methods Tissue microarray (TMA) blocks comprised of 100 surgically treated thymomas and 69 surgically treated thymic carcinomas were conducted. Tissue sections were incubated with primary antibodies against PD-L1 (clone E1L3N, 1:100), IDO (clone 10.1, 1:50), and FOXP3 (clone 236 A/E7, 1:50). Comparisons for categorical variables were performed using χ2 test and Fisher’s exact test. Survival analysis was established using Kaplan-Meier method and log-rank test. Univariate and multivariate analyses were performed using Cox regression model. Results and Conclusions High expression of PD-L1, IDO, and FOXP3 Tregs were identified in 36 (36%), 13 (13%), and 16 (16%) thymoma patients, respectively. High expression of PD-L1, IDO, and FOXP3 Tregs was associated with higher grade of tumor histology (P < 0.001, P = 0.007, and 0.014, respectively). High expression of PD-L1 was also associated with advanced Masaoka staging (P < 0.001). In patients with thymic carcinoma, high expression of PD-L1, IDO, and FOXP3 Tregs were identified in 25 (36%), 10 (14%), and 20 (29%) patients, respectively. Complete resection, low expression of IDO, and high expression of FOXP3 Tregs were associated with better overall survival (P = 0.001, 0.004, and 0.032, respectively), and progression-free survival (P < 0.001, P = 0.026, and 0.047, respectively) in multivariate analysis. In surgically treated thymoma, high PD-L1 expression was associated with advanced Masaoka staging. High PD-L1, IDO, and FOXP3 Tregs expression was associated with high grade histology. In surgically treated thymic carcinoma, significant survival benefit was noted in patients with complete resection, low IDO expression, and high FOXP3 Tregs expression." @default.
• W2891382714 created "2018-09-27" @default.
• W2891382714 creator A5002509654 @default.
• W2891382714 creator A5006341842 @default.
• W2891382714 creator A5010633780 @default.
• W2891382714 creator A5020831161 @default.
• W2891382714 creator A5028509711 @default.
• W2891382714 creator A5036098587 @default.
• W2891382714 creator A5041139618 @default.
• W2891382714 creator A5060246976 @default.
• W2891382714 date "2018-11-01" @default.
• W2891382714 modified "2023-10-12" @default.
• W2891382714 title "Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma" @default.
• W2891382714 cites W1600083774 @default.
• W2891382714 cites W1966481035 @default.
• W2891382714 cites W1976162569 @default.
• W2891382714 cites W1977023571 @default.
• W2891382714 cites W1977093042 @default.
• W2891382714 cites W1984562788 @default.
• W2891382714 cites W1988624936 @default.
• W2891382714 cites W1992957230 @default.
• W2891382714 cites W2001138132 @default.
• W2891382714 cites W2004528113 @default.
• W2891382714 cites W2009392040 @default.
• W2891382714 cites W2011099246 @default.
• W2891382714 cites W2011445390 @default.
• W2891382714 cites W2012510274 @default.
• W2891382714 cites W2016983859 @default.
• W2891382714 cites W2019607817 @default.
• W2891382714 cites W2035809865 @default.
• W2891382714 cites W2053934419 @default.
• W2891382714 cites W2064726511 @default.
• W2891382714 cites W2066944165 @default.
• W2891382714 cites W2076952890 @default.
• W2891382714 cites W2082237689 @default.
• W2891382714 cites W2086946343 @default.
• W2891382714 cites W2089265092 @default.
• W2891382714 cites W2094644987 @default.
• W2891382714 cites W2107350796 @default.
• W2891382714 cites W2108679802 @default.
• W2891382714 cites W2113846910 @default.
• W2891382714 cites W2120338564 @default.
• W2891382714 cites W2128640763 @default.
• W2891382714 cites W2132750605 @default.
• W2891382714 cites W2133536006 @default.
• W2891382714 cites W2135565086 @default.
• W2891382714 cites W2136926398 @default.
• W2891382714 cites W2141720524 @default.
• W2891382714 cites W2160834915 @default.
• W2891382714 cites W2165239516 @default.
• W2891382714 cites W2168558240 @default.
• W2891382714 cites W2169357214 @default.
• W2891382714 cites W2233871945 @default.
• W2891382714 cites W2323761957 @default.
• W2891382714 cites W2345307430 @default.
• W2891382714 cites W2351677294 @default.
• W2891382714 cites W2497684322 @default.
• W2891382714 cites W2527905628 @default.
• W2891382714 cites W2530711928 @default.
• W2891382714 cites W2539592320 @default.
• W2891382714 cites W2567450389 @default.
• W2891382714 cites W2594098019 @default.
• W2891382714 cites W2765836977 @default.
• W2891382714 cites W2784751095 @default.
• W2891382714 doi "https://doi.org/10.1016/j.lungcan.2018.09.002" @default.
• W2891382714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30429036" @default.
• W2891382714 hasPublicationYear "2018" @default.
• W2891382714 type Work @default.
• W2891382714 sameAs 2891382714 @default.
• W2891382714 citedByCount "24" @default.
• W2891382714 countsByYear W28913827142019 @default.
• W2891382714 countsByYear W28913827142020 @default.
• W2891382714 countsByYear W28913827142021 @default.
• W2891382714 countsByYear W28913827142022 @default.
• W2891382714 countsByYear W28913827142023 @default.
• W2891382714 crossrefType "journal-article" @default.
• W2891382714 hasAuthorship W2891382714A5002509654 @default.
• W2891382714 hasAuthorship W2891382714A5006341842 @default.
• W2891382714 hasAuthorship W2891382714A5010633780 @default.
• W2891382714 hasAuthorship W2891382714A5020831161 @default.
• W2891382714 hasAuthorship W2891382714A5028509711 @default.
• W2891382714 hasAuthorship W2891382714A5036098587 @default.
• W2891382714 hasAuthorship W2891382714A5041139618 @default.
• W2891382714 hasAuthorship W2891382714A5060246976 @default.
• W2891382714 hasConcept C104317684 @default.
• W2891382714 hasConcept C10515644 @default.
• W2891382714 hasConcept C126322002 @default.
• W2891382714 hasConcept C143998085 @default.
• W2891382714 hasConcept C144301174 @default.
• W2891382714 hasConcept C193270364 @default.
• W2891382714 hasConcept C203014093 @default.
• W2891382714 hasConcept C204232928 @default.
• W2891382714 hasConcept C2776349617 @default.
• W2891382714 hasConcept C2779159893 @default.
• W2891382714 hasConcept C2779727006 @default.
• W2891382714 hasConcept C38180746 @default.
• W2891382714 hasConcept C55493867 @default.
• W2891382714 hasConcept C71924100 @default.

• next